FDA Approves Lymphoseek to Help Locate Lymph Nodes

Wednesday, March 13, 2013 (Last Updated: 03/14/2013)

WEDNESDAY, March 13 (HealthDay News) -- The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.

Lymphoseek is an imaging drug that helps locate the lymph nodes, but it is not a cancer imaging drug, the agency stressed. It's the first lymph-node mapping drug to be approved by the FDA in 30 years.

The drug's safety and effectiveness were established in clinical trials involving 332 people with melanoma or breast cancer. The most common adverse reactions reported were pain and/or irritation at the injection site.

Lymphoseek is marketed by Navidea Biopharmaceuticals, based in Dublin, Ohio.

More Information

Specialties Cardiology
Hematology & Oncology
Internal Medicine

Health News Copyright © 2013 HealthDay. All rights reserved.


My Strange Affair with Sugar Continues
by Karen Wagner, MS, RD, CSO, LDN
March 17, 2014

My Cancer Experience
by Bob Riter
October 06, 2015